t(3;21)(q26;q22) with AML1 rearrangement in a de novo childhood acute monoblastic leukaemia
- 1 January 1996
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 92 (2) , 429-431
- https://doi.org/10.1046/j.1365-2141.1996.d01-1468.x
Abstract
T(3;21)(q26;q22) is a recurrent chromosomal abnormality in Philadelphia‐positive chronic myeloid leukaemia in blast crisis and in treatment‐related myelodysplastic syndrome and acute myeloid leukaemia. The molecular consequences of the t(3;21) are presently being unravelled; various transcripts between the AML1 gene in 21q22 and several unrelated genes, i.e. EAPEVI1 and MDS1, in 3q26 are generated, resulting in the formation of a chimaeric transcription factor. The t(3;21) has only rarely been described in de novo leukaemias and never before in an acute leukaemia in a child. We here present the clinical, cytogenetic and molecular genetic findings in a boy with a de novo acute monoblastic leukaemia with t(3;21)(q26;q22) and AML1 rearrangement.Keywords
This publication has 0 references indexed in Scilit: